Potential role of human papillomavirus in the development of subsequent primary in situ and invasive cancers among cervical cancer survivors

The recent licensure of human papillomavirus (HPV) vaccines will likely decrease the development of primary in situ and invasive cervical cancers and possibly other HPV‐associated cancers such as vaginal, vulvar, and anal cancers. Because the HPV vaccine has the ability to impact the development of >1 HPV‐associated cancer in the same individual, the risk of developing subsequent primary cancers among cervical cancer survivors was examined.

[1]  H. Weir,et al.  Using population‐based cancer registry data to assess the burden of human papillomavirus‐associated cancers in the United States: Overview of methods , 2008, Cancer.

[2]  Heikki Joensuu,et al.  Response: Re: Second Cancers Among 104760 Survivors of Cervical Cancer: Evaluation of Long-Term Risk , 2008 .

[3]  Bingshu E. Chen,et al.  Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk. , 2007, Journal of the National Cancer Institute.

[4]  B. Hutton,et al.  Prophylactic vaccination against human papillomavirus infection and disease in women: a systematic review of randomized controlled trials , 2007, Canadian Medical Association Journal.

[5]  R. Kahn,et al.  Sociodemographic Factors Associated With High-Risk Human Papillomavirus Infection , 2007, Obstetrics and gynecology.

[6]  J. Dillner,et al.  Translational Mini‐Review Series on Vaccines:
Monitoring of human papillomavirus vaccination , 2007, Clinical and experimental immunology.

[7]  M. Goodman,et al.  Excess risk of subsequent primary cancers among colorectal carcinoma survivors, 1975–2001 , 2006, Cancer.

[8]  Xavier Castellsagué,et al.  Chapter 1: HPV in the etiology of human cancer. , 2006, Vaccine.

[9]  F. Bray,et al.  The burden of HPV-related cancers , 2006 .

[10]  D. Vidrine,et al.  Successes and failures of the teachable moment , 2006, Cancer.

[11]  B. Pinto,et al.  Riding the crest of the teachable moment: promoting long-term health after the diagnosis of cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  B. Thompson,et al.  Colorectal carcinoma screening among Hispanics and non‐Hispanic whites in a rural setting , 2005, Cancer.

[13]  M. Plummer,et al.  Smoking and cervical cancer: pooled analysis of the IARC multi-centric case–control study , 2003, Cancer Causes & Control.

[14]  N. Muñoz,et al.  Chapter 3: Cofactors in human papillomavirus carcinogenesis--role of parity, oral contraceptives, and tobacco smoking. , 2003, Journal of the National Cancer Institute. Monographs.

[15]  D. Ahn,et al.  Cancer-related health behaviors and screening practices among Latinos: findings from a community and agricultural labor camp survey. , 2003, Ethnicity & disease.

[16]  S. Harlow,et al.  Cumulative risk of second primary cancers in women with index primary cancers of uterine cervix and incidence of lower anogenital tract cancers, Michigan, 1985-1992. , 1997, Gynecologic oncology.

[17]  P. Sparén,et al.  Second primary cancer after treatment for cervical cancer. An international cancer registries study , 1995, Cancer.

[18]  S. M.,et al.  Second primary cancer following treatment for cervical cancer. , 1984, Canadian Medical Association journal.

[19]  A. Barrett,et al.  NEW PRIMARY CANCERS IN PATIENTS ORIGINALLY PRESENTING WITH CARCINOMA OF THE CERVIX , 1976, British journal of obstetrics and gynaecology.